Literature DB >> 34128223

The additional diagnostic value of optical coherence tomography in clinically diagnosed basal cell carcinomas undergoing direct surgical excision.

F Adan1,2, P J Nelemans3, N W J Kelleners-Smeets1,2, J P H M Kessels4, T Brinkhuizen1,5, K Mosterd1,2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34128223      PMCID: PMC9291034          DOI: 10.1111/bjd.20579

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   11.113


× No keyword cloud information.
dear editor, Clinical examination appears to be very sensitive for diagnosing basal cell carcinoma (BCC) (90%), but the specificity is reported to be low (28·6–48·9%). , Additional use of dermoscopy can increase specificity to 54·3–55·6% compared with clinical examination alone. , With use of optical coherence tomography (OCT), a noninvasive diagnostic method, in addition to clinical and dermoscopic examination, it is possible to further increase the specificity to 76% at a sensitivity of 95%. , , These results apply to a population of patients with a clinical suspicion of BCC who had an indication for biopsy (e.g. high‐risk location or uncertainty about diagnosis). However, there are subgroups of patients, such as patients with a very high clinical suspicion for a low‐risk BCC or patients with multiple BCCs, who undergo direct surgical excision without prior histopathological verification of BCC diagnosis. , The aim of this study was to investigate whether OCT has additional diagnostic value in these subgroups of patients and whether it can help to reduce the risk of misclassification of non‐BCC lesions as BCC. Patients were included from August 2019 to January 2021 in one academic hospital and two general hospitals in the Netherlands. The study was approved by the local ethics committee and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients. All included lesions were highly suspicious for BCC based on clinical and dermoscopic examination and were scheduled for surgical excision without prior histopathological verification. Before surgery, an OCT scan was obtained for study purposes and the OCT diagnosis did not influence the treatment decision. A commercially available OCT device (< 7·5 μm lateral and < 5 μm axial optical resolution) was used for imaging (VivoSight, Michelson Diagnostics Ltd., Maidstone, UK). Analysis of OCT images was performed by one experienced observer using the morphological characteristics of BCC as previously described. Histopathological diagnosis was used as the gold standard. In total, 114 patients with a high clinical and dermoscopic suspicion of BCC were included; 59 (51·8%) in an academic hospital and 55 (48·2%) in general hospitals. The median age was 71 years (21–91) and 63 patients were male (55·3%). Lesions were located on the trunk (47·4%), head or neck area (35·1%) and extremities (17·5%). The results with respect to diagnostic accuracy of OCT are summarized in Table 1. According to histopathological diagnosis, 109 of 114 lesions were BCCs, which corresponds to a positive predictive value (PPV) of 95·6% for clinical and dermoscopic diagnosis. All 109 histopathologically verified BCCs were identified as such by OCT (sensitivity 100%) and the negative predictive value in cases with a negative OCT result was 100% (four of four). In only five of 114 lesions (4·4%) histopathology revealed an alternative diagnosis, i.e. seborrhoeic keratosis, solar elastosis, benign lichenoid keratosis, warty dyskeratoma and squamous cell carcinoma (SCC). OCT identified four of these five lesions as non‐BCC lesions. A benign lichenoid keratosis was misclassified as BCC by both clinical and dermoscopic examination and OCT. Furthermore, the SCC was excised with a 3‐mm margin and was radically removed.
Table 1

Diagnostic parameters for OCT in patients with high suspicion of low‐risk BCC according to clinical and dermoscopic diagnosis

HistologyTotal
BCCNo BCC
OCT positive for BCC1091110
OCT negative for BCC044
Total1095114

BCC, basal cell carcinoma; OCT, optical coherence tomography.

Diagnostic parameters for OCT in patients with high suspicion of low‐risk BCC according to clinical and dermoscopic diagnosis BCC, basal cell carcinoma; OCT, optical coherence tomography. The majority (97·4%) of the lesions in this study, all scheduled for excision, were diagnosed as nodular BCCs according to clinical and dermoscopic findings. There were only three superficial BCCs, as noninvasive treatment is usually preferred in superficial BCC. Of all 109 BCCs, 11 (10·1%) were superficial, 81 (74·3%) were nodular and 17 (15·6%) were found to be infiltrative upon histopathology. Clinical and dermoscopic examination misclassified eight of 11 (72.7%) superficial BCCs as nodular, whereas with OCT seven of 11 (63.6%) were misclassified as mixed superficial/nodular BCC. In total, 17 (100%) infiltrative BCCs were misclassified as nodular by clinical and dermoscopic examination and 14 (82.4%) were misclassified by OCT. With additional use of OCT, the PPV increased from 95·6% (without OCT) to 99·2% (109 of 110) with OCT. The decrease in the percentage of misclassifications was not significant, but a study with enough power to detect differences in this order of magnitude would require a much larger sample size. In another prospective study, the PPV of an OCT diagnosis that was made with high confidence was only 80%, but the BCC prevalence in that study was also lower (58·2%) than in the present study (95·6%). The PPV depends on prevalence and becomes lower if prevalence decreases. The use of OCT in addition to clinical and dermoscopic examination may reduce the risk of misclassification of non‐BCC lesions as BCC; however, this study also shows that in cases of high clinical and dermoscopic suspicion of BCC, this risk is already very low. The gain from additional use of OCT in patients with high clinical suspicion of BCC must be balanced against the financial investment required for the purchase of an OCT device and training of OCT users.

Author Contribution

Fieke Adan: Conceptualization (equal); Formal analysis (lead); Investigation (lead); Methodology (equal); Project administration (lead); Validation (equal); Visualization (lead); Writing‐original draft (lead); Writing‐review & editing (equal). Patty Nelemans: Conceptualization (equal); Formal analysis (lead); Investigation (equal); Methodology (lead); Supervision (equal); Validation (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Nicole WJ Kelleners‐Smeets: Conceptualization (equal); Investigation (equal); Methodology (equal); Supervision (equal); Validation (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Janneke Kessels : Conceptualization (equal); Investigation (equal); Methodology (equal); Supervision (equal); Validation (equal); Writing‐review & editing (equal). Tjinta Brinkhuizen: Conceptualization (equal); Investigation (equal); Methodology (equal); Supervision (equal); Validation (equal); Writing‐review & editing (equal). Klara Mosterd: Conceptualization (equal); Formal analysis (equal); Investigation (equal); Methodology (equal); Supervision (equal); Validation (equal); Visualization (equal); Writing‐original draft (equal); Writing‐review & editing (equal).
  8 in total

1.  Accuracy and predictors of basal cell carcinoma diagnosis.

Authors:  Jordan B Schwartzberg; George W Elgart; Paolo Romanelli; Ma Fangchao; Daniel G Federman; Robert S Kirsner
Journal:  Dermatol Surg       Date:  2005-05       Impact factor: 3.398

2.  The sensitivity and specificity of optical coherence tomography for the assisted diagnosis of nonpigmented basal cell carcinoma: an observational study.

Authors:  M Ulrich; T von Braunmuehl; H Kurzen; T Dirschka; C Kellner; E Sattler; C Berking; J Welzel; U Reinhold
Journal:  Br J Dermatol       Date:  2015-07-20       Impact factor: 9.302

Review 3.  Optical coherence tomography in the diagnosis of basal cell carcinoma.

Authors:  Alia Arif Hussain; Lotte Themstrup; Gregor Borut Ernst Jemec
Journal:  Arch Dermatol Res       Date:  2014-09-16       Impact factor: 3.017

4.  Optical Coherence Tomography for Noninvasive Diagnosis and Subtyping of Basal Cell Carcinoma: A Prospective Cohort Study.

Authors:  Kelly A E Sinx; Eva van Loo; Erwin H J Tonk; Nicole W J Kelleners-Smeets; Veronique J L Winnepenninckx; Patty J Nelemans; Klara Mosterd
Journal:  J Invest Dermatol       Date:  2020-03-06       Impact factor: 8.551

Review 5.  Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.

Authors:  Ketty Peris; Maria Concetta Fargnoli; Claus Garbe; Roland Kaufmann; Lars Bastholt; Nicole Basset Seguin; Veronique Bataille; Veronique Del Marmol; Reinhard Dummer; Catherine A Harwood; Axel Hauschild; Christoph Höller; Merete Haedersdal; Josep Malvehy; Mark R Middleton; Colin A Morton; Eduardo Nagore; Alexander J Stratigos; Rolf-Markus Szeimies; Luca Tagliaferri; Myrto Trakatelli; Iris Zalaudek; Alexander Eggermont; Jean Jacques Grob
Journal:  Eur J Cancer       Date:  2019-07-06       Impact factor: 9.162

6.  Accuracy of optical coherence tomography for the diagnosis of superficial basal cell carcinoma: a prospective, consecutive, cohort study of 168 cases.

Authors:  H M Cheng; S Lo; R Scolyer; A Meekings; G Carlos; P Guitera
Journal:  Br J Dermatol       Date:  2016-09-24       Impact factor: 9.302

7.  Guidelines of care for the management of basal cell carcinoma.

Authors:  John Y S Kim; Jeffrey H Kozlow; Bharat Mittal; Jeffrey Moyer; Thomas Olencki; Phillip Rodgers
Journal:  J Am Acad Dermatol       Date:  2018-01-10       Impact factor: 11.527

8.  Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy.

Authors:  Orit Markowitz; Michelle Schwartz; Eleanor Feldman; Amanda Bienenfeld; Amy K Bieber; Jeffery Ellis; Usha Alapati; Mark Lebwohl; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2015-10
  8 in total
  1 in total

1.  Fiber-based hand-held RCM-OCT probe for noninvasive assessment of skin lesions and therapy guidance.

Authors:  Gopi Maguluri; John Grimble; Mircea Mujat; Jesung Park; Aliana Caron; Nicusor Iftimia
Journal:  Transl Biophotonics       Date:  2022-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.